Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 29 January 1988:
Vol. 239. no. 4839, pp. 500 - 502
DOI: 10.1126/science.3277269
Prev | Table of Contents | Next

Articles

Science, Vol 239, Issue 4839, 500-502
Copyright © 1988 by American Association for the Advancement of Science

articles

Prevention of type I diabetes in nonobese diabetic mice by virus infection

MB Oldstone

Department of Immunology, Research Institute of Scripps Clinic, La Jolla, CA 92037.

The nonobese diabetic (NOD) mouse is an animal model of type I diabetes and develops a characteristic autoimmune lesion in the islets of Langerhans with lymphocytic infiltration and destruction of pancreatic beta cells. The result is hypoinsulinemia, hyperglycemia, ketoacidosis, and death. Diabetes usually begins by the sixth month of age but can occur earlier when young NOD mice are infused with lymphocytes from older NOD donors. When newborn or adult NOD mice were infected with a lymphotropic virus they did not become diabetic. The interaction between viruses and lymphocytes is pivotal in aborting diabetes, as established by experiments in which lymphocytes from virus-infected donors failed to transfer diabetes. In contrast, lymphocytes from age- and sex-matched uninfected donors caused disease. Therefore, viruses and, presumably, their products can be developed to be beneficial and may have potential as a component for treatment of human diseases. Further, these results point to the utility of viruses as probes for dissecting the pathogenesis of a nonviral disease.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Viral Trigger for Type 1 Diabetes: Pros and Cons.
C. M. Filippi and M. G. von Herrath (2008)
Diabetes 57, 2863-2871
   Full Text »    PDF »
Rotavirus Infection of Infant and Young Adult Nonobese Diabetic Mice Involves Extraintestinal Spread and Delays Diabetes Onset.
K. L. Graham, J. A. O'Donnell, Y. Tan, N. Sanders, E. M. Carrington, J. Allison, and B. S. Coulson (2007)
J. Virol. 81, 6446-6458
   Abstract »    Full Text »    PDF »
Salmonella typhimurium Infection in Nonobese Diabetic Mice Generates Immunomodulatory Dendritic Cells Able to Prevent Type 1 Diabetes.
T. Raine, P. Zaccone, P. Mastroeni, and A. Cooke (2006)
J. Immunol. 177, 2224-2233
   Abstract »    Full Text »    PDF »
Reovirus Delays Diabetes Onset but Does Not Prevent Insulitis in Nonobese Diabetic Mice.
J. D. Wetzel, E. S. Barton, J. D. Chappell, G. S. Baer, M. Mochow-Grundy, S. E. Rodgers, Y. Shyr, A. C. Powers, J. W. Thomas, and T. S. Dermody (2006)
J. Virol. 80, 3078-3082
   Abstract »    Full Text »    PDF »
Molecular Mimicry, Bystander Activation, or Viral Persistence: Infections and Autoimmune Disease.
R. S. Fujinami, M. G. von Herrath, U. Christen, and J. L. Whitton (2006)
Clin. Microbiol. Rev. 19, 80-94
   Abstract »    Full Text »    PDF »
Infections and Autoimmunity--Good or Bad?.
U. Christen and M. G. von Herrath (2005)
J. Immunol. 174, 7481-7486
   Abstract »    Full Text »    PDF »
TLR Activation Synergizes with Kilham Rat Virus Infection to Induce Diabetes in BBDR Rats.
D. Zipris, E. Lien, J. X. Xie, D. L. Greiner, J. P. Mordes, and A. A. Rossini (2005)
J. Immunol. 174, 131-142
   Abstract »    Full Text »    PDF »
Symptoms of Common Maternal Infections in Pregnancy and Risk of Islet Autoimmunity in Early Childhood.
L. C. Stene, K. Barriga, J. M. Norris, M. Hoffman, G. Klingensmith, H. A. Erlich, G. S. Eisenbarth, and M. Rewers (2003)
Diabetes Care 26, 3136-3141
   Abstract »    Full Text »    PDF »
DNA Vaccination with Heat Shock Protein 60 Inhibits Cyclophosphamide-Accelerated Diabetes.
F. J. Quintana, P. Carmi, and I. R. Cohen (2002)
J. Immunol. 169, 6030-6035
   Abstract »    Full Text »    PDF »
Toward Testing the Hypothesis that Group B Coxsackieviruses (CVB) Trigger Insulin-Dependent Diabetes: Inoculating Nonobese Diabetic Mice with CVB Markedly Lowers Diabetes Incidence.
S. Tracy, K. M. Drescher, N. M. Chapman, K.-S. Kim, S. D. Carson, S. Pirruccello, P. H. Lane, J. R. Romero, and J. S. Leser (2002)
J. Virol. 76, 12097-12111
   Abstract »    Full Text »    PDF »
Protection Against Diabetes and Improved NK/NKT Cell Performance in NOD.NK1.1 Mice Congenic at the NK Complex.
C. Carnaud, J.-M. Gombert, O. Donnars, H.-J. Garchon, and A. Herbelin (2001)
J. Immunol. 166, 2404-2411
   Abstract »    Full Text »    PDF »
Prevention of Type I Diabetes and Recurrent {beta}-Cell Destruction of Transplanted Islets.
R. H. Slover and G. S. Eisenbarth (1997)
Endocr. Rev. 18, 241-258
   Abstract »    Full Text »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)